§ Funding Round
Series C funding round for OncoResponse raising $41M in March 2021
Series C funding round for OncoResponse raising $41M in March 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Thompson Hutton (Thompson Hutton) | — | — |
3B Future Health Fund | — | — |
| Organization | — | |
| Organization | — | |
Canaan Partners | — | — |
ted koutouzis mdLEAD | Angel | ted koutouzis md |
| Angel | patrick hojlo, cfa | |
| Organization | — | |
RiverVest Venture Partners | — | — |
| Angel | daguan wang |
This company has completed 8 funding rounds. Current round is highlighted.
Total Raised
$214.5M
Top Valuation
-
OncoResponse raised $41M in a Series C round.
The round was announced on 03/01/21.
The round was led by ted koutouzis md.
